908 Devices (MASS) traded up 1.39 % during a 24 hours period ending at 01:14 PM Central Europe on Tuesday 27th. One 908 Devices stock can currently be bought for about USD 11.65 on popular exchanges. Current supply of 908 Devices stocks is 41.3 mn. 908 Devices has a current market capitalization of USD 475.3 mn and approximately USD 3.3 mn worth of 908 Devices was traded on exchanges in the last 24 hours. Since last month end, 908 Devices has traded -0.09 % down. Simple moving average of last 200 days is at USD 8.23. The highest price of past 52 weeks was recorded at USD 13.35 on 10/06/2026. 52 weeks low was at USD 5.02 on 01/02/2026.

Here is how related stocks have performed in the past 24 hours:

  • Mimedx (MDXG) traded down -1.53 % and now trades at USD 3.85. Mimedx has a market capitalisation of USD 564.1 mn. Current price/earnings ratio for Mimedx is 92.16.

  • Satellogic (SATL) traded down -3.13 % and now trades at USD 3.71. Current market capitalisation for Satellogic is USD 570.4 mn.

  • Crescent Biopharma (CBIO) traded down -0.47 % and now trades at USD 12.76. Current market capitalisation for Crescent Biopharma is USD 565.4 mn.

  • Shenandoah Telecommunication (SHEN) traded down -2.03 % and now trades at USD 10.14. Current market capitalisation for Shenandoah Telecommunication is USD 564.7 mn.

  • Entravision Communications (EVC) traded down -1.77 % and now trades at USD 6.12. Current market capitalisation for Entravision Communications is USD 570.3 mn. Entravision Communications has a current price to earnings ratio of 133.87. Entravision Communications Corp reported changes in the beneficial ownership of its Class A common stock, with both Gary Ferrera and Brian Krzanich receiving grants of restricted stock units that will vest in 2027. The filings indicate that no other directors or officers hold a ten‑percent stake and that the shares are held directly. The company’s directors have authorized their chief legal, financial, and operating officers to file the necessary Form 3, 4 or 5 disclosures on their behalf, ensuring compliance with Section 16 of the Securities Exchange Act. No additional securities were reported as beneficially owned by the directors at the filing dates. The updates confirm continued executive participation in the company’s equity plan.

About 908 Devices

908 Devices Inc. is a medical device manufacturing company based in Boston, Massachusetts, United States. The company specializes in designing and developing analytical devices for chemical and biomolecular analysis. These devices are intended for use in the life science and field forensic markets of the United States. You can find out more about their products and services on their website, which is www.908devices.com . The company’s stock is traded on the Nasdaq stock exchange.